NASDAQLPCN
Year
View
Form | Description | Date | Format |
---|---|---|---|
8-A12G | Registration of certain classes of securities 12(g) of the Securities Exchange Act | Mar 10, 2023 | ![]() ![]() ![]() ![]() |
We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.
Form | Description | Date | Format |
---|---|---|---|
8-A12G | Registration of certain classes of securities 12(g) of the Securities Exchange Act | Mar 10, 2023 | ![]() ![]() ![]() ![]() |